Physician profile
Rozan Razzouk
NPI 1245599596
$1,744.15
in general payments reported to CMS, 2019-2025
16 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $146 · 2021: $126 · 2023: $146 · 2024: $661 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168 · Education: $12.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.56 |
| Education | $12.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $673.16 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $462.92 | 2019-2025 | Lokelma, Farxiga, Breztri |
| Lexicon Pharmaceuticals, INC. | $122.10 | 2023 | Inpefa |
| Lilly USA, LLC | $93.69 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Kowa Pharmaceuticals America, INC. | $70.97 | 2019 | |
| Exact Sciences Corporation | $68.42 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $53.52 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $45.83 | 2019 | |
| Dexcom, INC. | $34.19 | 2024-2025 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $24.81 | 2020 | |
| Glaxosmithkline, LLC. | $20.35 | 2019 | |
| Allergan, INC. | $17.18 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.22 | 2019 | |
| Celgene Corporation | $14.98 | 2025 | Zeposia |
| Nalpropion Pharmaceuticals LLC | $14.70 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rozan Razzouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.